← All trials
NCT07086755
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 23, 2025
- Primary completion
- Jul 1, 2026
- Completion date
- Jul 1, 2026
- First posted
- Jul 25, 2025
- Last posted
- Nov 4, 2025
- Enrollment
- 1100
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Texas at HoustonLead sponsor
- University of Texas at HoustonSponsor investigator
- University of Texas at HoustonOfficial
- Akebia TherapeuticsCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.